Marker Therapeutics secures $16.1 million through private placement to advance MT-601 clinical trials for lymphoma treatment. Marker Therapeutics, Inc. announced the completion of a $16.1 million ...
HOUSTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the ...
HOUSTON – When someone you love passes away, the process of planning the memorial and everything else can be overwhelming. There is a lot to do and you are also grieving, so there are some things you ...
Survivors treated with 2 different kinds of chemotherapy experienced similar general and mental health, activity limitations, and increase in risk for mortality, The delay in clip placement was ...
Add Yahoo as a preferred source to see more of our stories on Google. Nov. 11—AIKEN — Aiken City Council on Nov. 10 unanimously approved placement of a historical marker memorializing the lynching of ...
Strategic financing supports clinical advancement in Phase 1 APOLLO study investigating MT-601 in patients with lymphoma who relapsed after anti-CD19 CAR-T cells HOUSTON, Dec. 19, 2024 (GLOBE NEWSWIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results